0001493152-20-017640.txt : 20200911
0001493152-20-017640.hdr.sgml : 20200911
20200911161720
ACCESSION NUMBER: 0001493152-20-017640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200910
FILED AS OF DATE: 20200911
DATE AS OF CHANGE: 20200911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GLECKEL LOUIS MD
CENTRAL INDEX KEY: 0001164762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 201171128
MAIL ADDRESS:
STREET 1: C/O PROHEALTH CARE ASSOCIATES LLP
STREET 2: 2800 METRUS AVE
CITY: LAKE SUCCESS
STATE: NY
ZIP: 11042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
BUSINESS PHONE: 2153450919
MAIL ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2020-09-10
0
0000868278
ProPhase Labs, Inc.
PRPH
0001164762
GLECKEL LOUIS MD
621 N. SHADY RETREAT ROAD
DOYLESTOWN
PA
18901
1
0
0
0
Option (right to buy)
2.83
2020-09-10
4
A
0
100000
0.00
A
2027-09-09
Common Stock
100000
100000
D
The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on September 30, 2020 and the remaining portion vesting pro rata in equal monthly installments beginning October 31, 2020 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 10, 2020.
/s/ Louis Gleckel, MD
2020-09-11